ConductScience.org, home

Paper40407337

An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity.

Jia Y and 9 others. Antimicrob Agents Chemother, 2025. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity. Papers, record 40407337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40407337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Mycobacterium abscessus activity.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
2025
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
2
iCite
Revised in PubMed
2025-08-25
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jia YYapinghttps://orcid.org/0009-0008-0034-8230
2Fan JJunsheng
3Tan ZZhili
4Li AAnqi
5He SSiyuan
6Lin YYani
7Li JJuan
8Zhang ZZhemin
9Li BBinghttps://orcid.org/0000-0003-0234-044X
10Chu HHaiqinghttps://orcid.org/0000-0002-9168-7295

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Mycobacterium abscessusMajor topic
Anti-Bacterial AgentsMajor topic
Mycobacterium Infections, NontuberculousMajor topic
Enoyl-(Acyl-Carrier-Protein) Reductase (NADH)Major topic
Animals
Microbial Sensitivity Tests
Mice
Macrophages
Humans
Female

Source PubMed

Download CSV of topics

Grants7

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
81672063National Natural Science Foundation of ChinaPubMed
81971973National Natural Science Foundation of ChinaPubMed
82270005National Natural Science Foundation of ChinaPubMed
81800003National Natural Science Foundation of ChinaPubMed
22ZR1452000Natural Science Foundation of Shanghai MunicipalityPubMed
23S11901400Science and Technology Innovation Plan Of Shanghai Science and Technology CommissionPubMed
20244Z0017Shanghai Municipal Health Commission Excellence ProjectPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
135969055A Novel Leucyl-tRNA Synthetase Inhibitor, MRX-6038, Expresses Anti-Mycobacterium abscessus Activity In Vitro and In Vivo.Antimicrob Agents Chemother2022https://conductscience.org/library/papers/35969055PubMed
225568071Direct inhibitors of InhA are active against Mycobacterium tuberculosis.Sci Transl Med2015https://conductscience.org/library/papers/25568071PubMed
322290346Mycobacterium abscessus: a new antibiotic nightmare.J Antimicrob Chemother2012https://conductscience.org/library/papers/22290346PubMed
48284673inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis.Science1994https://conductscience.org/library/papers/8284673PubMed
531507579Clinical Efficacy and Adverse Effects of Antibiotics Used to Treat Mycobacterium abscessus Pulmonary Disease.Front Microbiol2019https://conductscience.org/library/papers/31507579PubMed
630689764Mycobacterium abscessus and Antibiotic Resistance: Same As It Ever Was.Clin Infect Dis2019https://conductscience.org/library/papers/30689764PubMed
729712658Determination of MIC Distribution and Mechanisms of Decreased Susceptibility to Bedaquiline among Clinical Isolates of Mycobacterium abscessus.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29712658PubMed
832317266KatG as Counterselection Marker for Nontuberculous Mycobacteria.Antimicrob Agents Chemother2020https://conductscience.org/library/papers/32317266PubMed
932086501Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus.Nat Rev Microbiol2020https://conductscience.org/library/papers/32086501PubMed
1028575382In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis.J Antimicrob Chemother2017https://conductscience.org/library/papers/28575382PubMed
1121292749
Deletion of the mmpL4b gene in the Mycobacterium abscessus glycopeptidolipid biosynthetic pathway results in loss of surface colonization capability, but enhanced ability to replicate in human macrophages and stimulate their innate immune response.
Microbiology (Reading)2011https://conductscience.org/library/papers/21292749PubMed
1229437627Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29437627PubMed
1330880280M ycobacterium abscessus pulmonary disease: individual patient data meta-analysis.Eur Respir J2019https://conductscience.org/library/papers/30880280PubMed
1426488279Assembly of the Mycobacterial Cell Wall.Annu Rev Microbiol2015https://conductscience.org/library/papers/26488279PubMed
1529277667Triclosan and its derivatives as antimycobacterial active agents.Eur J Pharm Sci2018https://conductscience.org/library/papers/29277667PubMed
1632314749Fast chemical force microscopy demonstrates that glycopeptidolipids define nanodomains of varying hydrophobicity on mycobacteria.Nanoscale Horiz2020https://conductscience.org/library/papers/32314749PubMed
1737314394New therapeutic strategies for Mycobacterium abscessus pulmonary diseases - untapping the mycolic acid pathway.Expert Rev Anti Infect Ther2023https://conductscience.org/library/papers/37314394PubMed
1832636299Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.Eur Respir J2020https://conductscience.org/library/papers/32636299PubMed
1919171799A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae.Antimicrob Agents Chemother2009https://conductscience.org/library/papers/19171799PubMed
2024752273Lack of antimicrobial bactericidal activity in Mycobacterium abscessus.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24752273PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn Papers
41519752Efficacy of regimens targeting Mycobacterium abscessus in vitro and in vivo.BMC Microbiol2026https://conductscience.org/library/papers/41519752

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40407337

GET https://conductscience.org/api/papers/v1/40407337/references?page=2